Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Liabilities and Shareholders Equity (2016 - 2025)

Healthy Extracts (HYEX) has 11 years of Liabilities and Shareholders Equity data on record, last reported at $26.2 million in Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity rose 961.3% year-over-year to $26.2 million; the TTM value through Sep 2025 reached $33.5 million, up 228.45%, while the annual FY2024 figure was $2.4 million, 9.75% down from the prior year.
  • Liabilities and Shareholders Equity reached $26.2 million in Q3 2025 per HYEX's latest filing, up from $2.5 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $26.2 million in Q3 2025 and bottomed at $2.4 million in Q4 2024.
  • Average Liabilities and Shareholders Equity over 5 years is $4.0 million, with a median of $2.8 million recorded in 2022.
  • Peak YoY movement for Liabilities and Shareholders Equity: decreased 22.78% in 2021, then soared 961.3% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $3.0 million in 2021, then decreased by 8.2% to $2.8 million in 2022, then dropped by 5.25% to $2.6 million in 2023, then decreased by 9.75% to $2.4 million in 2024, then soared by 1001.4% to $26.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $26.2 million in Q3 2025, $2.5 million in Q2 2025, and $2.4 million in Q1 2025.